They are very active. So far I see size holdings in Genvec, NuPath, Invion, Benitec, Genspera.
And the most interesting by far is a 5% stake in SRPT. That's the one I have been using to show how inflexible the FDA is on placebo arm. It is also the binary event of the year for bio's and the most controversial by far. Stock is 20 and will be 5 or 40+ at any time. FDA has taken a lot of heat on this one.
But, it is a wild, huge spec which may tell you something about Sabby.
I am also betting on an AA there within the next month, but own a spread to lessen risk. I am sure Sabby is hedged on equity with puts and calls but still a huge spec.
Sabby must know they have little to no chance of selling this super illiquid security above their cost in any type of size unless there is some good news coming. They might have already made a nice profit using that .34 stock to cover what was shorted for so long above that level. This we do not know yet. And if they did, they will be giving back those profits.
If nothing illegal has been done(front running shorting), Shabby is a holder like the rest of us until good news takes us higher. They cant play any games here with the warrants if no equity volume. And, they will be a big time loser if Nk or nice trial endpoints or heart, stroke, wounds partner/license, or grants don't happen in the near term. This is the reality of trading here which all of us have experienced first hand. So Shabby, welcome to the hotel California of the investment world that is rgrx.
Bottom line, rgrx got some much needed cash. I don't see this as putting pressure to the downside, but might cap gains on upticks on good news as Sappy seeks to exit. Who knows, maybe they have a plan that might benefit all of us.
Hey sno, check out wall st journal editorial today on srpt trial and the FDA. They really bash FDA for demanding a placebo. Like you say, some will avoid trial now since all taking placebo will die.
They were caught twice. Once with clrx for 50k shares. And the other was a large cap: BLUE for 2000 shares. One was shorted on the same day as offering(clrx)..not real bright. And the other was done within a couple days. I don't know what the restricted time table is. Our shorts were done a month and more ahead of this deal. Maybe Sno knows how long shorts restricted before deal.
Its possible Sabby has refined their trading to fall within the guidelines. And increased their size by many times.
In any event, their prior behavior demands a look at their books by the sec. If nothing there, no harm. But, if true, how does one figure out how high stock should have been during that period of relentless selling? And, also implies working with JJ who had to have known months ahead that Sabby would get deal.
Wow, where else can investors have so much fun?????? !!!!!!!!!!
Interesting. Looks like they were caught before. It seems more than coincidental that we had all that short selling earlier; right before this deal. They would have to be pretty stupid to try the same thing again. But, who knows? And short selling just went very quiet a couple weeks ago.
If true, cheap deal price and huge amount of shorting beforehand (by Sabby?) would support share price around here. Maybe one reason we have maintained a price well above that .34
Anyway, as usual, more drama for long termers to endure.
Have a good 4th!!!!!!!!!!!!!
Anyone ever heard of them? Will have to check out this weekend.
Looks like they will be a holder for at least 12 months as they are protected from dilution with agreement to buy if rgrx issues again at a lower price. Don't think JJ thinks that's a possibility.
Hey hopewill. I still have that abusive, vulgar private message you sent me.(Rob followers are mostly devoid of any basic decency, and I have many PM's to prove) I sent it to Blue to have you kicked off IV, but since you are a Rob zombie, he did not care. Its obvious your PM was in violation of the IV rules, yet you remain and I was kick off. Its all part of the paperwork sent to the SEC.
Have a good day hopewill.
Small cap, you are a typical rob Zombie. If you can find a post where I ever made a physical threat against Rob, please copy and post it here. The truth is I never did and never had. I always pointed out Robs incorrect posts and his inclination to try and revise his own history. I also called to attention the fact that he has a serious gambling problem which may influence his pumping of various securities. Followers of Rob should be aware of these things.........the SEC is now.
The owner of IV is in serious trouble for allowing Rob to run a public forum as a private message board. I broke no IV rules and was banned without cause. That is a fact..............good luck to you
Vaso will make enough to pay the inflated salaries of Ma and Castle and the rest of the Crew. Shareholders will once again see little to nothing in terms of stock price. And that is just the way management likes it. Run vaso like a private company which is beholden to no shareholder. What a disgrace Ma is.
Good for you. Yes, it is possible to make money on Rob's recs; just do the opposite. He is a great contrary indicator.
He is on IV now(his own private message board) hyping the new upgrade of ziop by that bucket shop Griffin. Who would listen to that analyst.? He has NEVER been right about ziop or xon.
CAE use was misguided. We all get it. It seems pointless to keep repeating that sentiment, but have at it.
We do not know if JJ and Koreans were forced into using CAE, as other early trials on various dry eye drugs did use it. But the focus now is that it will not be used in the future trial, There is no precedent for using such and adverse environment in other trials. Does a diabetic have to drink multiple Cokes in the last week of a trial to see what happens to insulin levels. How about a week of sun for a melanoma trial? Or a nice pack or two during a lung cancer trial/ The whole concept is ridiculous and will be dropped here.
And NK will never get around having a placebo arm. Just take a look at what the FDA made srpt do in their new trial? And if they were forced to use, you can bet the FDA has not interest in cutting rgrx a break on that point.
And finally, stock is not maintaining this market cap waiting for 2018 and beyond. Once easy FDA endpoints agreed upon this summer, trial will be almost totally derisked and JV or rgrx will be sold. Gtree is not waiting that long. They are not going to get a sales force and sell TB4; that is silly.
Recent finance gives jj the waiting time and negotiating leverage he needs. He did not sell off another "piece" of rgrx's pipeline or dry eye coverage on the cheap.
Wait continues, but lots of positives to look forward to. Of course some fixated in that rear view mirror will choose not to look ahead. So be it.
More unusual OTM call action today. 1200 july 110 calls. With stock down, buyers paying up .23 cents at .45. Offer now 50 cents
IGEN revisited. Recommendations do little, short interest up. Roche is up to their old games again. It is in their best interest to have stock as low as possible during negotiations. As with IGEN, Roche was caught illegally shorting stock to put pressure on Igen to accept lowball offer. Roche plays hardball and flaunts regulations.
I have never seen a penny bio come with this size placement, under the market(that is usual) and do less than avg volume on the day. Normally, you see many times avg volume. Along with the lack of volume, price action was very subdued, again pointing to a dearth of traders and very committed longs; not a bad thing.
It would be nice to know the buyer. I do not think it is Kirk. He is having a handful with the poor price action in his biggest holdings; ziop and xon. He has almost become toxic on the street now as his many recent promises have fallen very flat; notice all the lawsuits involved on those 2 companies. Also, shorts are all over his holdings. So, just as well it aint him. When i was corresponding with JJ, we talked about the need of placing stock with a real buyer, not an atm like Lincoln. He was very aware, so much so that I think he might have sacrificed a couple pennies on the deal to get the right buyer. Action today suggest that. IMHO
What was lost today was also an unusual item on this type of deal. Sno, you must have noticed? These deals are almost always announced after the close and most often on a Friday. But here, JJ put it out loud and proud on a Monday morning; start of the trading week. No attempt to hide the deal. Good job on that one. Price of deal must have been run by the Koreans, so they are ok with that and the buyer. And they have a serious vested interest in success here. So, nothing to do but hang tight and wait for positive news to hit. No going concern statements anymore.
Great Video, and sadly reminds us all why we originally invested in this stock. Phrases like "evidence overwhelming" and real "impact on health", are just inspirational. It really just shows how lacking leadership has been at VASO. I hope Ma takes a look before he cashes his next check; or should I say his next 30 pieces of silver.
How do you see that? Renew can advertise as increased quality of life for healthy patients. Vaso would have to apply for same as angina is there target market. Huge difference if you really want to market eecp to the masses. And vaso has shown NO inclination to spend money or time applying to the FDA. Ma sold us out to Leiberman, Castle and the investment bankers. But, why should he care? He gets nice fat salary.
"The Renew® NCP-5 is the only ECP system with a cleared indication for the use in healthy patients."